Radiolabeled APIs for the Conduct of Human ADME Studies of Oncology Compounds
Journal Title: International Journal of Cancer and Clinical Research - Year 2017, Vol 4, Issue 2
Abstract
Human ADME (Absorption, Distribution, Metabolism, and Excretion) studies of new chemical entities are an important part of the drug development process. These studies are normally performed by using a radioactive tracer (C-14 or H-3) blended with a therapeutic dose of non-radioactive drug in about four to six subjects. The radiolabeled API (Active Pharmaceutical Ingredient) is utilized to evaluate the recovery and track the metabolic fate and physiological disposition of the drug. More challenges are faced regarding subject and site selection and supply of C-14 labeled drug product when performing these studies with oncology compounds. If the compound is suitable to study in healthy volunteers, the strategy employed will be similar to what is normally conducted with non-oncology compounds. But if the compound is not suitable to study in healthy volunteers (e.g. a cytotoxic drug), different strategies including recruitment of patients and availability of pure radioactive drug product whenever a patient becomes available for the study must be employed. These studies generally extend over a period of six months to a year. Because of this, stability studies of manufactured radiolabled compound assume importance. Two approaches ((Microtracer-AMS (Accelerator Mass Spectrometry) and the traditional method) used for these studies will be described. Detailed information will be explained by using three examples (Compounds A, B, and C, with microtracer - AMS method in healthy volunteers, microtracer - AMS method in patients, and traditional method in patients respectively).
Bioactive Peptides from Legumes as Anticancer Therapeutic Agents
Food proteins are a source of nutraceutical and bioactive peptides that promote health and prevent diseases. Legume seed proteins have been widely studied to produce peptides (protein fragments) with a diversity of biolo...
Trastuzumab Emtansine in Patients with HER2-Positive Metastatic Breast Cancer: a Multicenter Japanese Retrospective Study
Introduction: Trastuzumab emtansine (T-DM1) is currently approved for the treatment of patients with HER2-positive metastatic breast cancer after failure of prior anti-HER2 therapies. However, the efficacy of T-DM1 in pa...
The Role of Notch Signaling in Liver Diseases: Contribution to Development and Cancer
Liver tissue consists of several types of cells such as hepatocytes, endothelial cells, stellate cells, cholangiocytes, and immune cells, all with essential functions. The liver plays an important role in metabolism beca...
Assessing Response to Chemoradiotherapy on 18F-FDG PET Images in Non-Small Cell Lung Cancer using New Approaches of Histogram and Gray Level Co-Occurrence Matrix
Purpose To investigate inherent information provided by 18F-FDG PET to ameliorate shortcomings of relying on visual inspection or sole SUV measurement in treatment assessing. Patients and methods Twelve patients with ne...
Physiological Effort in Submaximal Fitness Tests Predicts Weight Loss in Overweight and Obese Men with Prostate Cancer in a Weight Loss Trial
Background Obesity and weight gain after the diagnosis of prostate cancer are associated with an increased risk of prostate cancer recurrence and mortality; individualized plans to help prostate cancer survivors maintain...